#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14848	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2182	676.7	0	.	n	.	0	A69G	SNP	69	69	A	402	402	G	848	G,A,C	788,2,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14848	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2182	676.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1783	1783	T	869	T	793	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14848	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2182	676.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1517	1517	C	882	C,A	820,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14848	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2182	676.7	0	HET	.	.	.	C1269T	.	1269	1269	C	1602	1602	C	825	C,T	628,134	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14848	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2182	676.7	0	HET	.	.	.	C873T	.	873	873	C	1206	1206	C	904	C,T	683,153	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14848	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2182	676.7	0	HET	.	.	.	C1137T	.	1137	1137	C	1470	1470	C	817	C,T	543,218	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27504	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3583	765.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1684	1684	A	924	A	857	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27504	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3583	765.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2318	2318	C	858	C	802	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27504	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3583	765.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2392	2392	A	865	A	818	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27504	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3583	765.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2944	2944	C	838	C	791	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_W_01420c	folP.WHO_W_01420c	1	1	539	1816	folP	852	852	99.88	folP.l15.c4.ctg.1	1568	115.3	0	.	p	.	0	E151K	NONSYN	451	453	GAA	790	792	AAA	183;185;185	A;A;A	173;175;174	.	.
folP.WHO_W_01420c	folP.WHO_W_01420c	1	1	539	1816	folP	852	852	99.88	folP.l15.c4.ctg.1	1568	115.3	1	SNP	p	R228S	1	.	.	682	684	AGC	1021	1023	AGC	197;198;196	A;G;C	183;182;179	folP.WHO_W_01420c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4816	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3443	139.4	1	SNP	p	S91F	0	.	.	271	273	TCC	634	636	TCC	156;157;157	T;C;C	145;147;145	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4816	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3443	139.4	1	SNP	p	D95N	0	.	.	283	285	GAC	646	648	GAC	157;154;156	G;A;C	146;144;146	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4816	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3443	139.4	1	SNP	p	D95G	0	.	.	283	285	GAC	646	648	GAC	157;154;156	G;A;C	146;144;146	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1438	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1252	114.4	1	SNP	p	G45D	0	.	.	133	135	GGC	452	454	GGC	187;185;186	G;G;C	176;173;176	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	710	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1101	64.3	0	.	n	.	0	A197.	DEL	197	197	A	613	613	A	171	A	163	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5562	parC	2304	2304	99.78	parC.l15.c4.ctg.1	2984	185.7	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1643	1645	GCA	229;230;232	G;C;A,G	211;207;208,1	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5562	parC	2304	2304	99.78	parC.l15.c4.ctg.1	2984	185.7	1	SNP	p	D86N	0	.	.	256	258	GAC	596	598	GAC	227;229;229	G;A;C	220;219;222	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5562	parC	2304	2304	99.78	parC.l15.c4.ctg.1	2984	185.7	1	SNP	p	S87I	0	.	.	259	261	AGT	599	601	AGT	231;228;230	A;G;T	218;219;216	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5562	parC	2304	2304	99.78	parC.l15.c4.ctg.1	2984	185.7	1	SNP	p	S87R	0	.	.	259	261	AGT	599	601	AGT	231;228;230	A;G;T	218;219;216	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5562	parC	2304	2304	99.78	parC.l15.c4.ctg.1	2984	185.7	1	SNP	p	S87W	0	.	.	259	261	AGT	599	601	AGT	231;228;230	A;G;T	218;219;216	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5562	parC	2304	2304	99.78	parC.l15.c4.ctg.1	2984	185.7	1	SNP	p	S88P	0	.	.	262	264	TCC	602	604	TCC	232;230;230	T;C;C	218;216;217	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3784	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2615	144.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1520	1522	GGC	174;173;173	G;G;C	166;163;162	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	3672	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2368	154.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1250	1252	GCA	197;202;201	G;C,A;A	185;186,1;190	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3672	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2368	154.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1253	1255	ATC	203;201;204	A;T;C	191;190;194	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3672	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2368	154.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1265	1267	GTG	201;197;198	G;T;G	192;186;189	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3672	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2368	154.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1265	1267	GTG	201;197;198	G;T;G	192;186;189	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3672	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2368	154.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1769	1771	ACC	184;182;182	A;C;C	169;169;171	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3672	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2368	154.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1823	1825	GCG	172;174;176	G;C;G	156;139;147	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3672	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2368	154.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1823	1825	GCG	172;174;176	G;C;G	156;139;147	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3672	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2368	154.6	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1946	1948	GGC	166;165;165	G;G;C	152;152;152	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3672	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2368	154.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1955	1957	GGC	163;161;160	G;G;C	148;146;144	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3672	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2368	154.6	1	SNP	p	L552S	0	.	.	1654	1656	CTG	1973	1975	CTG	147;148;149	C,G;T;G	107,4;101;115	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5746	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3106	184.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1557	1559	CCG	205;206;204	C;C;G	186;186;186	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2034	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1761	115.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	526	526	C	157	C	144	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2988	porB1b	1047	1047	99.14	porB1b.l6.c4.ctg.1	1637	181.5	0	.	p	.	0	N38E	NONSYN	112	114	AAT	416	418	GAA	261;257;256	G;A;A	246;244;243	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2988	porB1b	1047	1047	99.14	porB1b.l6.c4.ctg.1	1637	181.5	0	.	p	.	0	K120N	NONSYN	358	360	AAG	662	664	AAT	270;268;268	A;A;T	245;245;246	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2988	porB1b	1047	1047	99.14	porB1b.l6.c4.ctg.1	1637	181.5	0	.	p	.	0	N134D	NONSYN	400	402	AAT	704	706	GAT	252;253;255	G;A;T	229;231;231	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2988	porB1b	1047	1047	99.14	porB1b.l6.c4.ctg.1	1637	181.5	0	.	p	.	0	P175S	NONSYN	523	525	CCA	827	829	TCA	245;243;244	T;C,A;A,C	225;226,1;227,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2988	porB1b	1047	1047	99.14	porB1b.l6.c4.ctg.1	1637	181.5	0	.	p	.	0	A218V	NONSYN	652	654	GCC	956	958	GTC	246;246;245	G;T;C	228;225;225	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2988	porB1b	1047	1047	99.14	porB1b.l6.c4.ctg.1	1637	181.5	0	.	p	.	0	W257L	NONSYN	769	771	TGG	1073	1075	TTG	235;234;231	T;T,G;G	218;216,1;214	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2988	porB1b	1047	1047	99.14	porB1b.l6.c4.ctg.1	1637	181.5	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1286	1288	GCA	229;225;227	G;C;A	210;205;207	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2988	porB1b	1047	1047	99.14	porB1b.l6.c4.ctg.1	1637	181.5	1	SNP	p	D121N	0	.	.	361	363	GAC	665	667	GAC	267;268;269	G;A;C	243;245;244	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2988	porB1b	1047	1047	99.14	porB1b.l6.c4.ctg.1	1637	181.5	1	SNP	p	A121D	1	.	.	361	363	GAC	665	667	GAC	267;268;269	G;A;C	243;245;244	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	11426	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4890	233.0	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1978	1980	CAT	235;235;236	C;A;T	219;220;222	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1236	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	915	133.2	1	SNP	p	V57M	1	.	.	169	171	ATG	475	477	ATG	264;264;263	A;T;G,A	245;245;243,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
